相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Isolated tumor endothelial cells maintain specific character during long-term culture
Kohei Matsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors
Tomoshige Akino et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study
C. Falandry et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Dkk-3 expression in the tumor endothelium: A novel prognostic marker of pancreatic adenocarcinomas
Dominic Fong et al.
CANCER SCIENCE (2009)
Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells
Noritaka Ohga et al.
CANCER SCIENCE (2009)
Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies
Kyoko Hida et al.
CANCER SCIENCE (2008)
The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation
Gerold Untergasser et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Endothelial progenitor cell-derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA
Maria Chiara Deregibus et al.
BLOOD (2007)
Regulation of COX-2-mediated signaling by α3 type IV noncollagenous domain in tumor angiogenesis
Chandra Shekhar Boosani et al.
BLOOD (2007)
Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors
Jamie Case et al.
EXPERIMENTAL HEMATOLOGY (2007)
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study
Cesare Gridelli et al.
LANCET ONCOLOGY (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
Endothelial cell COX-2 expression and activity in hypoxia (Publication with Expression of Concern. See vol. 1868, 2023)
Rebecca J. Cook-Johnson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia
Abderrahmane Kaidi et al.
CANCER RESEARCH (2006)
Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy
MR Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors
DN Amin et al.
CANCER RESEARCH (2006)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel
I Csiki et al.
CLINICAL CANCER RESEARCH (2005)
NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation
N Smakman et al.
UROLOGY (2005)
A new perspective on tumor endothelial cells: Unexpected chromosome and centrosome abnormalities
K Hida et al.
CANCER RESEARCH (2005)
Contribution of bone marrow-derived endothelial cells to human tumor vasculature
BA Peters et al.
NATURE MEDICINE (2005)
Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade
HQ Li et al.
CANCER RESEARCH (2004)
Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck
ZG Chen et al.
CLINICAL CANCER RESEARCH (2004)
Tumor-associated endothelial cells with cytogenetic abnormalities
K Hida et al.
CANCER RESEARCH (2004)
Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells
I Rajantie et al.
BLOOD (2004)
Regulation of angiogenesis by hypoxia: role of the HIF system
CW Pugh et al.
NATURE MEDICINE (2003)
Tumor response to radiotherapy regulated by endothelial cell apoptosis
M Garcia-Barros et al.
SCIENCE (2003)
Efficient mobilization and recruitment of marrow-derrived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors
S Rafii et al.
GENE THERAPY (2002)
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
D Lyden et al.
NATURE MEDICINE (2001)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Host cyclooxygenase-2 modulates carcinoma growth
CS Williams et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
AL Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)